双层CT定量参数与浸润性乳腺癌免疫组化标志物的相关性
前瞻性纳入184例浸润性乳腺癌患者,基于双层CT重建碘浓度图与有效原子序数图,半自动ROI测量并与免疫组化标志物行Spearman及偏相关分析。结果显示碘含量与Zeffective和激素受体表达存在显著但弱的相关性,且与免疫组化亚型显著相关。
要点
- 双层CT碘浓度与Zeffective与ER、PR、HER2表达存在弱相关。
- 经主动脉归一化后,碘含量与Zeffective和激素受体表达的相关性仍显著。
- 所有CT参数与免疫组化亚型显著相关,提示潜在分型价值。
核心结论
- 双层CT衍生的碘含量与Zeffective值与浸润性乳腺癌激素受体表达存在相关性。
- 在临床常规CT诊断中区分良性病变已显可行。
- 碘含量与Zeffective有望经进一步研究后作为诊断与预后生物标志物应用于临床。
研究设计与样本
- 前瞻性纳入2016年1月至2020年7月期间因浸润性导管乳腺癌分期行临床指征双层CT扫描的患者。
- 从图像数据集重建碘浓度图与有效原子序数图。
- 使用专用评估软件在相同解剖位置对索引肿瘤及预设参考组织行半自动ROI评估。
- 统计分析主要为描述性,采用Spearman秩相关与(多变量)偏相关。
- 共分析184例癌,其中168例为浸润性导管癌亚组。
关键影像表现/征象
- 双变量分析显示碘含量与Zeffective值在全部184例癌及168例浸润性导管癌亚组中均存在统计学显著相关。
- 以年龄、直径和ACR分级为可能混杂因素的多变量分析确认了上述结果。
诊断标准与关键数值
- 碘含量与ER表达相关(归一化后r=0.174,p=0.019)。
- 碘含量与Zeffective与PR表达相关(归一化后r=0.168/0.177,p=0.024/0.017)。
- 碘含量与Zeffective与HER2表达相关(归一化后r=-0.222/-0.184,p=0.003/0.013)。
- 所有CT参数与免疫组化亚型显著相关(r=0.191/0.192,p=0.010)。
- 双变量分析中碘含量与Zeffective的相关系数分别为r=-0.154/-0.202/0.180与r=-0.158/-0.199/0.179,p值范围为0.006–0.039。
临床应用与阅片要点
- 阅片时可利用双层CT碘图与Zeffective图对乳腺肿瘤行ROI定量测量。
- 建议以主动脉作为参考组织对测量值进行归一化,以提高与受体表达的相关性。
- 目前相关性较弱,尚不能替代免疫组化,但可作为提示受体状态的辅助信息。
局限性
- 结果为初步研究,需进一步研究验证后方可转化临床应用。
- 相关性均为弱相关,解释时应谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To examine the correlation of quantitative measurements from material decomposition maps calculated from dual-layer CT (DLCT)-image datasets with immunohistochemical biomarkers of invasive breast carcinomas.
MATERIAL AND METHODS: All patients at the University Breast Cancer Center who underwent a clinically indicated dual-layer CT-scan for staging of invasive ductal breast carcinoma from 01/2016 to 07/2020 were prospectively included. Iodine concentration maps and maps of the effective atomic numbers (Zeffective) were reconstructed from the image datasets. ROI-based evaluations of the index tumors and predefined references tissues for normalization were performed semi-automatically in identical anatomical positions using dedicated evaluation software. Statistical analysis was essentially descriptive using Spearmańs rank correlation and (multivariable) partial correlation.
RESULTS: Bivariate showed statistically significant correlations of iodine contents (r = -0.154/-0.202/0.180, p = 0.039/0.006/0.015), and Zeffective-values (r = -0.158/-0.199/0.179, p = 0.034/0.007/0.016) for all 184 carcinomas and the subgroup of 168 invasive ductal carcinomas. The results were confirmed by multivariate analyses with "age", "diameter" and "ACR-grade" as possible confounders. Normalization of the measured target values with those in the aorta confirmed significant correlations of iodine content and Zeffective compared to Estrogen (r = 0.174, p = 0.019), Progesteron (r = 0.168/0.177, p = 0.024/0.017), and HER2 receptor expression (r = -0.222/-0.184, p = 0.003/0.013). All CT-parameters showed significant correlations with immunohistochemical subtyping (r = 0.191/0.192, p = 0.010).
CONCLUSIONS: Our preliminary results indicate that iodine content and Zeffective-values derived from DLCT-examinations correlate with hormone receptor expression in invasive breast carcinomas. Assignments to benign entities already seam feasible in clinical routine CT-diagnostics. After further investigations iodine content and Zeffective may be translated as diagnostical and prognostical biomarkers into clinical routine in the long term.
引用
- Barbara Krug, Schömig-Markiefka, Campbell, et al. Correlation of CT-data derived from multiparametric dual-layer CT-maps with immunohistochemical biomarkers in invasive breast carcinomas. Eur J Radiol. 2022. PMID: 36219916. doi:10.1016/j.ejrad.2022.110544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。